Showing results (111-120 of 660) with videos related to
Sort By:
Pageof 66
Current Oncology (Toronto, Ont.)|January 24, 2025
The Immune Landscape and Its Potential for Immunotherapy in Advanced Biliary Tract CancerAndry Santoso, Iris Levink, Rille Pihlak, et al.Cancer Treatment Reviews|January 1, 2019
Integrative molecular analysis of colorectal cancer and gastric cancer: What have we learnt?Avani Athauda, Eva Segelov, Zohra Ali, et al.International Journal of Radiation Oncology, Biology, Physics|June 3, 2015
Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C TrialFrancesco Sclafani, Clare Peckitt, David Cunningham, et al.European Journal of Cancer (Oxford, England : 1990)|July 20, 2005
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancerIan Chau, Andrew R Norman, David Cunningham, et al.Clinical Colorectal Cancer|November 14, 2017
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control StudyHamzeh Kayhanian, Emily Goode, Francesco Sclafani, et al.Journal of the National Cancer Institute|June 25, 2014
TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trialFrancesco Sclafani, David Gonzalez, David Cunningham, et al.British Journal of Haematology|March 22, 2003
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphomaIan Chau, Mark Harries, David Cunningham, et al.Clinical & Experimental Metastasis|December 15, 2015
Management of resectable colorectal lung metastasesSing Yu Moorcraft, George Ladas, Anne Bowcock, et al.BMC Cancer|August 22, 2014
A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRIIan Chau, Florence Joulain, Sheikh Usman Iqbal, et al.Cancers|October 17, 2019
Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer CenterAlexandros Georgiou, Shelize Khakoo, Penelope Edwards, et al.Pageof 66